deferasirox:
Showing 26 - 50 of 54
Hemochromatosis, MDS Trial in Bergen (Deferasirox, Venesection)
Terminated
- Hemochromatosis
- Myelodysplastic Syndromes
- Deferasirox
- Venesection
-
Bergen, NorwayHaukeland University Hospital, Clinical Trial Unit
Jan 20, 2017
Myelodysplastic Syndrome, Transfusional Iron Overload Trial in Worldwide (Deferasirox)
Terminated
- Myelodysplastic Syndrome
- Transfusional Iron Overload
-
Caen, Cedex, France
- +9 more
Mar 1, 2017
AL-Hijama in Thalassmia Major Trial in Tanta (Al-hijamah, Deferasirox)
Unknown status
- AL-Hijama in Thalassmia Major
- Al-hijamah
- Deferasirox
-
Tanta, Gharbia, Egypt
- +1 more
Apr 24, 2017
Myelodysplastic Syndrome, Thalassemia Trial in Moscow, Saint-Petersburg, St. Petersburg (Deferasirox)
Completed
- Myelodysplastic Syndrome
- Thalassemia
-
Moscow, Russian Federation
- +2 more
Dec 8, 2016
Anemia, Sickle Cell, Transfusion Hemosiderosis Trial in Los Angeles (deferasirox)
Terminated
- Anemia, Sickle Cell
- Transfusion Hemosiderosis
-
Los Angeles, CaliforniaChildrens Hospital Los Angeles
Dec 15, 2016
MDS, Hemosiderosis Trial in Italy (Deferasirox)
Completed
- Myelodysplastic Syndromes
- Hemosiderosis
-
Alessandria, Italy
- +16 more
Nov 21, 2016
Beta-Thalassemia, Iron Overload Trial in Toronto (Amlodipine, Deferasirox)
Unknown status
- Beta-Thalassemia
- Iron Overload
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 24, 2016
Acute Myeloid Leukemia, Acute Lymphoid Leukemia Trial (Cytarabine, Deferasirox)
Unknown status
- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
- (no location specified)
Feb 24, 2016
Systemic Inflammatory Process, Anemia Trial (iron sucrose, Deferasirox, endotoxin)
Completed
- Systemic Inflammatory Process
- Anemia
- iron sucrose
- +3 more
- (no location specified)
Nov 16, 2015
Transfusional Iron Overload, Transfusional Hemosiderosis Trial in Worldwide (Core Study: Deferasirox, Core Study: Deferoxamine,
Completed
- Transfusional Iron Overload
- Transfusional Hemosiderosis
- Core Study: Deferasirox
- +5 more
-
Toronto, Ontario, Canada
- +20 more
Aug 13, 2014
Porphyria Cutanea Tarda Trial in Dallas (Deferasirox)
Completed
- Porphyria Cutanea Tarda
-
Dallas, TexasUT Southwestern Medical Center at Dallas - Dermatology Clinical
Jan 9, 2014
Non-transfusion Dependent Thalassemia Trial in Worldwide (deferasirox, )
Completed
- Non-transfusion Dependent Thalassemia
- deferasirox
- placebo
-
Oakland, California
- +20 more
May 20, 2013
Transfusional Iron Overload in ß-thalassemia Trial in Worldwide (Deferasirox)
Completed
- Transfusional Iron Overload in β-thalassemia
-
Los Angeles, California
- +48 more
May 24, 2011